Luts & Greenleigh Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
6,500
+111
+2% +$25.9K 1.26% 16
2025
Q4
$1.32M Sell
6,389
-124
-2% -$24.5K 1.12% 21
2025
Q3
$1.21M Sell
6,513
-484
-7% -$82.9K 1.08% 22
2025
Q2
$1.07M Buy
6,997
+20
+0.3% +$3.07K 1.03% 22
2025
Q1
$1.16M Sell
6,977
-297
-4% -$46.5K 1.15% 19
2024
Q4
$1.05M Sell
7,274
-402
-5% -$62.3K 1.04% 22
2024
Q3
$1.24M Sell
7,676
-60
-0.8% -$9.56K 1.19% 17
2024
Q2
$1.13M Buy
+7,736
New +$1.15M 1.18% 18
2023
Q4
$969K Buy
6,184
+2
+0% +$307 1.22% 17
2023
Q3
$963K Sell
6,182
-45
-0.7% -$7.42K 1.19% 19
2023
Q2
$1.03M Buy
6,227
+1,060
+21% +$171K 1.27% 17
2023
Q1
$801K Sell
5,167
-33
-0.6% -$5.33K 1.02% 20
2022
Q4
$918K Buy
+5,200
New +$898K 1.16% 19

Other funds holding JNJ

Luts & Greenleigh Group's JNJ Position: Q1 2026 in Review

Luts & Greenleigh Group increased its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, buying an estimated $25.9K and bringing the position to 6,500 shares worth $1.59M. The position accounts for 1.26% of the portfolio, ranked #16.

Luts & Greenleigh Group first reported a position in JNJ in Q4 2022 and has held it in 13 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Luts & Greenleigh Group held 6,500 shares of Johnson & Johnson worth $1.59M as of Q1 2026.
  • Luts & Greenleigh Group bought 111 Johnson & Johnson shares in Q1 2026, an estimated $25.9K.
  • Johnson & Johnson made up 1.26% of Luts & Greenleigh Group's portfolio in Q1 2026, its #16 holding.
  • Luts & Greenleigh Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 13 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Luts & Greenleigh Group's 13F filing for Q1 2026, filed 5 May 2026.